ProMIS Neurosciences Inc (PMN) reported a quarterly adjusted loss of 1 cent per share for the quarter ended December 31, 2024, which is an improvement compared to the same quarter last year when the company reported an EPS of -29 cents1. However, the company reported a revenue of zero for the quarter, which is a significant decline from the previous year's revenue.
- Revenue Trend: PMN's revenue trend in Q4 2024 was negative, with the company reporting zero revenue for the quarter. This is a significant decline from the previous year's revenue, which indicates a challenging period for the company in terms of generating income.
- Expense Trend: PMN's expenses were higher than revenue in Q4 2024, as indicated by the net income of $9.3 million reported in the 10-Q filing for the quarter ended September 30, 20242. The company's operating loss for the three months ended September 30, 2024, was $4.4 million, and the net income for the quarter was $9.3 million2. This suggests that while revenue was low, expenses were managed to some extent to prevent a larger loss.
Overall, PMN faced a difficult quarter in terms of revenue generation, but managed to control expenses to some extent, resulting in a slightly improved financial performance compared to the previous year.